Input: Read this: Energy gives rise to weight when it is trapped in a system with zero momentum, where it can be weighed. It is also equivalent to mass, and this mass is always associated with it. Mass is also equivalent to a certain amount of energy, and likewise always appears associated with it, as described in mass-energy equivalence. The formula E = mc, derived by Albert Einstein (1905) quantifies the relationship between rest-mass and rest-energy within the concept of special relativity. In different theoretical frameworks, similar formulas were derived by J. J. Thomson (1881), Henri Poincare (1900), Friedrich Hasenohrl (1904) and others (see Mass-energy equivalence#History for further information).
Question: What quantifies the relationship between rest-mass and rest-energy outside of the concept of special relativity?

Output: unanswerable

Input: Read this: Airports may also contain premium and VIP services. The premium and VIP services may include express check-in and dedicated check-in counters. These services are usually reserved for First and Business class passengers, premium frequent flyers, and members of the airline's clubs. Premium services may sometimes be open to passengers who are members of a different airline's frequent flyer program. This can sometimes be part of a reciprocal deal, as when multiple airlines are part of the same alliance, or as a ploy to attract premium customers away from rival airlines.
Question: What are two groups that are usually in the frequent flyer program?

Output: unanswerable

Input: Read this: New sequencing technologies, such as massive parallel sequencing have also opened up the prospect of personal genome sequencing as a diagnostic tool, as pioneered by Manteia Predictive Medicine. A major step toward that goal was the completion in 2007 of the full genome of James D. Watson, one of the co-discoverers of the structure of DNA.
Question: Whose complete genetic information was recorded in 2007?

Output: James D. Watson

Input: Read this: In 1971, Akira Endo, a Japanese biochemist working for the pharmaceutical company Sankyo, identified mevastatin (ML-236B), a molecule produced by the fungus Penicillium citrinum, as an inhibitor of HMG-CoA reductase, a critical enzyme used by the body to produce cholesterol. Animal trials showed very good inhibitory effect as in clinical trials, however a long term study in dogs found toxic effects at higher doses and as a result mevastatin was believed to be too toxic for human use. Mevastatin was never marketed, because of its adverse effects of tumors, muscle deterioration, and sometimes death in laboratory dogs.
Question: What was discovered in short term studies?

Output:
unanswerable